Vance, Melisa
Llanga, Telmo
Bennett, Will
Woodard, Kenton
Murlidharan, Giridhar
Chungfat, Neil
Asokan, Aravind
Gilger, Brian
Kurtzberg, Joanne
Samulski, R. Jude
Hirsch, Matthew L.
Article History
Received: 3 December 2015
Accepted: 1 February 2016
First Online: 22 February 2016
Competing interests
: R. Jude Samulski is the founder and a shareholder at Asklepios BioPharmaceutical. He receives research support through the University of North Carolina from Asklepios. BioPharmaceutical. He holds patents that have been licensed by UNC to Asklepios. Biopharmaceutical, for which he receives royalties. He has consulted for Baxter Healthcare and has received payment for speaking. Matthew Hirsch has disclosed AAV8G9-optIDUA to the University of North Carolina.